Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$0.47 - $1.05 $11,966 - $26,733
-25,460 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$1.22 - $2.41 $31,061 - $61,358
25,460 New
25,460 $41,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.